This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In its efforts to streamline and rationalise the sampling procedure and maintain a centralised monthly database the Central Drugs Standard Control Organisation (CDSCO) has released the final version of the regulatory guidelines for sampling of drugs, cosmetics and medical devices by drugs inspectors of the Central and State drug authorities.
The amended provisions under the Jan Vishwas (Amendment of Provisions) Act, 2023 notified by the Central government last year for removal of stringent punishments such as imprisonment from some of the Sections of the Drugs and Cosmetics Act, 1940, will be in force from December 31, 2024.
Even as the Centre has listed the New Drugs, Medical Devices and Cosmetics Bill, 2023 to be tabled in Parliament during the current session, industry members are apprehensive that the new bill may mean centralisation of licensing and other powers to the Central drug regulatory authority and it may also have provisions which may harm […]
Ten collective stakeholders of Indian healthcare industry, including the industry associations of medical devices manufacturers, patient interest group, and healthcare providers, have jointly demanded to the Union health minister Dr Mansukh Mandaviya to recall the New Drugs, Medical Devices & Cosmetics Bill, 2023 that is listed to be tabled in (..)
The Drugs and Cosmetics Act, 1940: Genesis to Zenith admin Tue, 04/04/2023 - 16:00 ABOUT AUTHOR Dr. R. Thakur Chief Editor, Journal of Pharmaceutical Research Krupanidhi College of Pharmacy, Bengaluru, India. Email : drramsthakur@gmail.com
Bioengineered artificial skin has become an increasingly important and reliable platform for researchers to test the safety and efficacy of drugs and cosmetics. It can be produced on a large scale and is a good substitute for animal testing. The most promising technologies for production of in vitro models include 3D bioprinting.
Although provisions of the Pharmacy Practice Regulations (PPR) 2015 are not there in the Drugs and Cosmetics (D&C) Act 1940 but are framed under the Pharmacy Act 1948, the steps now being taken by the drugs control administration (DCA) in Tamil Nadu in a motive to strengthen the dispensing activities in pharmacies are completely agreeing […] (..)
The Union Ministry of Ayush (MoA) is taking steps to amend the Drugs and Cosmetics Act, 1940 to add the French Homoeopathic Pharmacopoeia and the European Pharmacopoeia under the standards on which the imports and manufacturing of homoeopathic drugs will be allowed in the country.
Taking into account the four main components of regulator, industry, trade and patient/consumer in a medicine value supply chain, the Drugs and Cosmetics (D&C) Rules, 1945 and D&C Act, 1940 needs an urgent revamp as there is no clause of compensation for ADRs in patients, according to drug regulatory experts.
The key issue is the lack of dedicated guidelines on the disposal under the Drugs & Cosmetics Act. There is a growing concern about the lack of stringent norms on disposal of unused and expired medicines that pose a threat to health and the environment.
The medical devices industry has urged the Centre to ensure obligation on the part of the buyer or users to purchase or use only those medical devices with required licenses and certifications under the New Drugs, Medical Devices and Cosmetics (NDMDC) Bill, 2022, the draft of which has been circulated by the Union Health Ministry […].
Rice Ferment Filtrate in Cosmetics. Kumar Organic Products Research Centre Pvt. Read more about Rice Ferment Filtrate in Cosmetics Log in or register to post comments About Author. Vinay Kumar Singh. . Head-Formulation. Tue, 03/08/2022 - 17:07.
Goddard III A research team from Caltech and the UCLA Samueli School of Engineering has demonstrated a promising way to efficiently convert carbon dioxide into ethylene — an important chemical used to produce plastics, solvents, cosmetics and other important products globally. Credit: Yu Huang and William A.
In the cosmetics industry, innovation is key to staying ahead of the competition. As consumer preferences evolve and regulatory demands increase, cosmetics companies are under pressure to prove the safety and efficacy of their products through rigorous clinical studies.
As such, we are seeing an uptick in research examining the therapeutic effects of cannabis and its constituents. While there isn’t a significant amount of research on cannabidiol (CBD), it’s easily accessible in the U.S. This can make research challenging, but not insurmountable. Funding Research on Cannabis.
Many Certified Cosmetic Surgeons Not Trained in Surgical Discipline. 13, 2020 — Many physicians advertising themselves as board-certified cosmetic surgeons are not as qualified as plastic surgeons, according to a study published in the November issue of Plastic and Reconstructive Surgery. Professional. FRIDAY, Nov.
June 8, 2021 /PRNewswire/ — Allergan Aesthetics, an AbbVie company (NYSE: ABBV ), is changing the way BOTOX ® Cosmetic, the #1 selling neurotoxin treatment 1 , is connecting with consumers. “BOTOX ® Cosmetic is honoring and celebrating the dynamic people who use our products. IRVINE, Calif.
Previously, Darshan was on the editorial board of cosmetics and personal products for FDAnews where guided the publication with his clinical trial and pharmaceutical expertise. The post Clinical Research Data Transparency with Darshan Kulkarni appeared first on Clinical Trial Podcast & Blog. To learn more, visit [link].
Daxxify was FDA-approved for similar cosmetic purposes as Botox and other neuromodulators like Dysport and Xeomin. Many people choose to undergo non-invasive cosmetic procedures to prevent or reduce the appearance of signs of aging. ng of the core active ingredient. Bringing Daxxify into Offices.
Food, Drug, and Cosmetic Act, established in 1938, helped set the standard for research studies today, shaping how medications and treatments are evaluated and released. However, there are still some misconceptions surrounding research studies. Read more The post Are Research Studies Right for Me?
Pharmacy faculty member studies properties that are environmentally friendly Credit: University of Cincinnati University of Cincinnati cosmetic scientist Harshita Kumari has received a research grant for more than $700,000 for a multi-year study to explore certain new proprietary surfactants for industrial applications and personal care products such (..)
As per Section 201(h)(1) of the Food, Drug, and Cosmetic Act, a device is an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, […] The post US FDA Medical Device Applications appeared first on ProRelix Research.
It’s nutraceutical segment offers rehydration, nutrition, vitamin supplements and cosmetics. The company operates branch offices, research facilities and factories in Japan. OPC is headquartered in Chiyoda-ku, Tokyo, Japan.
It’s nutraceutical segment offers rehydration, nutrition, vitamin supplements and cosmetics. The company operates branch offices, research facilities and factories in Japan. OPC is headquartered in Chiyoda-ku, Tokyo, Japan.
More Study Details About the Research Center: Location Research Center: Validated Claim Support Location: Teaneck, New Jersey Lead Researcher: Anna Hardy About the Study Are you curious about your skin’s unique characteristics? Participate in this exclusive skin research study and discover the secrets of your skin tone!
The platform has a built-in currency called ‘Robux’ that can be used to buy some games, as well as “cosmetics” – digital items for character customisation like hats, hairstyles or clothing. EndeavorRx will connect to Roblox, and playing it will unlock cosmetics that draw on the design of the game.
New method could advance next-generation applications in medicine, cosmetics, and petroleum recovery Credit: Paul Ashby and Tom Russell/Berkeley Lab and Science Advances Liquid structures – liquid droplets that maintain a specific shape – are useful for a variety of applications, from food processing to cosmetics, medicine, and even petroleum (..)
The pursuit for the most effective and safe products requires rigorous clinical research, which involves meticulous trial design, recruitment, data collection, and subsequent analysis. Let’s delve into how these solutions can accelerate research and bring products to market faster.
The American Conference Institute (“ACI”) will be hosting a series of go-to forums on critical topics including novel therapeutics, cosmetics/personal care products and Paragraph IV disputes. Claud will be featured at the Legal, Regulatory, and Compliance Forum on Cosmetics & Personal Care Products in New York, NY.
The clinical research landscape is rapidly evolving. As it becomes more complex with growing volumes of data, evolving regulations, and the pressure for faster drug development, traditional methods of clinical research management are no longer sufficient. Improved Scalability As research organizations grow, so do their needs.
opaque, contain zinc oxide or titanium dioxide, and may be cosmetically unacceptable to some patients. The rarity of the disease makes it difficult for researchers to study, and run clinical trials for its therapies. Betacarotene is used to improve light tolerance significantly. It causes huge distress to the younger population.
Both the FDA’s Center for Drug Evaluation and Research (CDER) and its Center for Biologics Evaluation and Research (CBER) have regulatory responsibility for therapeutic biological products, which are subject to both the Federal Food, Drug and Cosmetic (FD & C) Act and the Public Health Service (PHS) Act.
They are used as biocatalysts in pharmaceutical production, such as polymer synthesis, cosmetics, flavouring agents, and similar. To further understand the key themes and technologies disrupting the pharmaceutical industry, access GlobalData’s latest thematic research report on Pharmaceutical.
As a reminder, the BIMO program oversees a wide range of activities related to FDA-regulated research, including human and animal studies, and covers the full gamut of FDA centers (CDER, CBER, CDRH, CFSAN, CTP, and CVM). Maintain accurate and detailed records of all research activities, including raw data, test results, and correspondence.
The licensing deal marks an expansion of the specialty drugmaker’s neurosciences R&D focus, which to date has concentrated mainly on its neurotoxin franchise headed by Dysport (abobotulinumtoxinA), used for cosmetic applications as well as other indications like spasticity and cervical dystonia.
New research published in Science Advances has suggested that a natural cyan blue extracted from red cabbage could replace synthetic blue dyes in food. Food coloring is an essential part of the food and beverage industry; however, some research suggests that using synthetic dyes is not healthy for the consumer.
The letter , which was sent on January 4, 2021, stated that several of the company’s products violated section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. § Some examples include: “[A]ntiviral, ongoing clinical research on effectiveness against COVID-19”. “4-Thieves W]anted to share my COVID story. [t]here
On April 23, 2021, the Food Allergy Safety, Treatment, Education, and Research (FASTER) Act was signed into law, declaring sesame as the 9th major food allergen recognized by the U.S., effective Jan. Federal Register. Related Information. The FDA, an agency within the U.S. Source link: [link].
Ipsen’s John Chaddock tells us why the company is investing heavily in neurotoxin research and how he hopes to raise awareness among young scientists and the NHS. One such expert is John Chaddock, VP head of research, external innovation & early development at Ipsen. Now, he says, neurotoxin research is truly global.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
246 
Let's personalize your content